Paperwork Reduction Act; Notice of Intent To Collect; Comment Request

---
identifier: "/us/fr/2013-01762"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Paperwork Reduction Act; Notice of Intent To Collect; Comment Request"
title_number: 0
title_name: "Federal Register"
section_number: "2013-01762"
section_name: "Paperwork Reduction Act; Notice of Intent To Collect; Comment Request"
positive_law: false
currency: "2013-01-29"
last_updated: "2013-01-29"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Office of National Drug Control Policy"
document_number: "2013-01762"
document_type: "notice"
publication_date: "2013-01-29"
agencies:
  - "Office of National Drug Control Policy"
fr_citation: "78 FR 6141"
fr_volume: 78
fr_action: "The Office of National Drug Control Policy (ONDCP) seeks public comment on its proposed collection of information."
---


#  Paperwork Reduction Act; Notice of Intent To Collect; Comment Request

**AGENCY:**

Office of National Drug Control Policy.

**ACTION:**

The Office of National Drug Control Policy (ONDCP) seeks public comment on its proposed collection of information.

**SUMMARY:**

ONDCP proposes the extension of three existing data collection instruments used in the production of advertising for the National Youth Anti-Drug Media Campaign and for advertising tracking.

*Purpose:* The existing data collection instruments are critical to the continuity and improvement of the National Youth Anti-Drug Media Campaign.

*Type and Title of Collections:* Qualitative Research, OMB 3201-0011, uses focus groups. Copy Testing, OMB 3201-0006, consists of 15-minute online interviews. Tracking Study, OMB 3201-0010, consists of 15-minute online interviews.

*Frequency:* Qualitative Research and Copy Testing performed quarterly. Tracking Study performed weekly.

*Affected Public:* Teenagers and adult influencers of teenagers.

*Estimated Burden:* Qualitative Research, $19,800; Copy Testing, $16,500; Tracking Study, $37,700.

*Additional information:* Collection instruments similar to those proposed are available at the Information Collection Review section of *http://www.reginfo.gov/public/jsp/Utilities/index.jsp.*

*Contact:* Address comments or questions to Andrew Hertzberg through any of the following: Executive Office of the President, Office of National Drug Control Policy, Washington DC 20503; *[email protected]* ; (202) 395-6721 (fax); or, (202) 395-6353 (voice).

Signed in Washington DC on January 23, 2013.

Daniel R. Petersen,

Deputy General Counsel.